New York-based private equity firm Arsenal Capital Partners, has acquired Fluoro-Seal Holdings a provider of plastic barrier, adhesion and surface enhancement products. Fluoro-Seal currently operates 15 plants in the US and an additional seven international sites through joint ventures or licenses.
Arsenal Capital Partners, a leading New York-based private equity firm that invests in middle-market specialty industrial, healthcare, and financial services companies, announced today the acquisition of Fluoro-Seal Holdings LLC, a leading provider of unique plastic barrier, adhesion and surface enhancement products and services as well as manufacturer of value-added materials.
Fluoro-Seal provides barrier treatment for plastic bottles, containers and fuel tanks going into diverse end uses including agricultural, automotive, industrial and consumer cleaning solutions, personal care, and pharmaceutical markets. The company also performs surface modifications on films, fabrics and other substrates to increase and promote adhesion properties, abrasion resistance, corrosion resistance and wettability. In addition, the company develops and supplies surface modified polymer particles and fibers, which are used as performance additives for plastics, rubber, paints, coatings and composites. The company develops its own technology and has a long track record of innovation, continuous improvement and excellent quality. Fluoro-Seal currently operates 15 plants in the U.S. and an additional seven international sites through joint ventures or licenses.
“We are delighted with the opportunity to invest in an innovative company with a great track record of providing unique high quality solutions, products and services to its customers. The acquisition of Fluoro-Seal builds on Arsenal’s portfolio and established expertise in the Specialty Chemicals and Materials sectors. We look forward to supporting Fluoro-Seal’s proven record of innovation in the barrier treatment and surface modification markets and helping the company achieve more of its potential in the global markets,” said John Televantos, a Partner at Arsenal and Co-Head of the firm’s Specialty Industrials Group.
“We chose Arsenal Capital as the partner for our company after evaluating numerous other options. We believe that they are uniquely capable of supporting our company’s growth in existing and new markets in the U.S. and also globally. This is a positive development for our customers, employees, suppliers and our other partners,” said Bill Brown and Monty Ballard, co-founders of Fluoro-Seal.
“We are pleased to be partnering with a great leadership team at Fluoro-Seal, especially Bill and Monty, to expand the scope of the company and leverage its unique technologies,” added Tim Zappala, Partner at Arsenal and Co-Head of the firm’s Specialty Industrials Group.
Fluoro-Seal joins Arsenal’s extensive portfolio of investments in the specialty industrials sector. The firm’s current investments in this sector include Royal Adhesives & Sealants, a leading producer of proprietary, high-performance adhesives, sealants and coatings; Novolyte Technologies, a world leading manufacturer of specialty electrolyte materials and high performance solvents for lithium ion battery and energy storage applications; Charter Brokerage, a premier non-asset based third party logistics provider to the petroleum and petrochemical industries; Source Refrigeration & HVAC, the leading independent provider of commercial refrigeration services in North America; DG3, a leading, global provider of commercial printing and graphic communication services; and Velsicol Chemical, a leading manufacturer of chemical intermediates used in applications such as agrochemicals. Previous investments in the sector include IDQ Holdings, Genovique Specialties, Sermatech International, and Vertellus Specialties.
About Arsenal Capital Partners
Arsenal Capital Partners is a leading New York-based private equity firm that invests in middle-market specialty industrial, healthcare and financial services companies. Arsenal makes investments in sectors where the firm has significant prior knowledge and experience. Arsenal targets businesses that have the potential for further value creation by working closely with management to accelerate growth and leverage the firm’s operational improvement capabilities. Arsenal currently has $800 million of committed equity capital.